Pharmacokinetic Study of Marine Active in Health Men

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

Hyperuricemia is often associated with metabolic syndrome, which is a known precursor of atherosclerosis. The Yaizu Suisankagaku Industry Company have developed industrial production, named Marine Active. Human clinical trials showed reduction of creatine phosphokinase activity and sero-uric acid. Randomize, double blind clinical trial is entrust to our hospital. This study design is blood sampling from the health men who take 1 gm of marine active to analyse the pharmacokinetics of anserine.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: China Medical University Hospital

Criteria

Inclusion Criteria:

-Male volunteers, age between 20 to 35 years

Exclusion Criteria:

• Chronic medical history

• Significant liver or renal dysfunction,

• Have been administrated by any drug within 2 weeks before the initiation of study.